Drug Profile
Research programme: antivirals - Microbiotix
Alternative Names: MBX 468; MBX 685; MBX 769SLatest Information Update: 27 Sep 2018
Price :
$50
*
At a glance
- Originator Microbiotix
- Developer Microbiotix; University of Michigan
- Class Antivirals; Cyclopropanes; Purine nucleosides; Small molecules
- Mechanism of Action Virus internalisation inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C; Human herpesvirus 6 infections; Human herpesvirus 8 infections; Influenza A virus H5N1 subtype
- Discontinued Epstein-Barr virus infections; Hepatitis B
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hepatitis-C in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Human-herpesvirus-6-infections in USA
- 04 Nov 2017 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype in USA